The CRISPR-powered Diagnostic SLEUTH - Summary - MDSpire

The CRISPR-powered Diagnostic SLEUTH

Novel DNA-guided system may support future RNA diagnostics and mutation detection

  • May 22, 2026

  • 2 min

Share

Objective:

To develop a modified CRISPR–Cas12a system using DNA guides for RNA detection and cutting.

Key Findings:
  • The DNA-guided Cas12a system accurately recognizes and cleaves RNA with strong sequence specificity.
  • The system can detect RNA targets at low concentrations without preamplification.
  • The assay showed complete agreement with RT-qPCR results in testing with SARS-CoV-2 clinical samples.
  • The system can distinguish single-nucleotide sequence differences, aiding mutation detection.
  • Minimal off-target effects were observed in transcriptome analysis.
Interpretation:

The study presents a new platform for RNA detection that could enhance existing CRISPR-based diagnostics.

Limitations:
  • DNA-guided complexes were less stable than conventional RNA-guided systems.
  • Intracellular RNA knockdown was modest.
Conclusion:

The findings indicate that programmable RNA targeting is achievable with DNA-guided CRISPR technology, suggesting potential for future molecular diagnostics.

Original Source(s)

The CRISPR-powered Diagnostic SLEUTH

  • May 22, 2026

Related Content

Liquid Biopsy Supports Precision Oncology

Experts highlight clinical value, workflow integration, and real-world impact in lung and breast cancer diagnostics

  • May 22, 2026

  • 8 min
Vibe-Reporting Comes to Omics? 

Jesse Meyer’s vibe-coded app is impressive, says Randall Julian, but don’t call it a “platform”

  • May 22, 2026

  • 4 min
Transforming Urologic Care in Philadelphia and Worldwide. The Fox Chase – Temple Urologic Institute.

In just four years, the Fox Chase – Temple Urologic Institute has leveraged the expertise of two renowned institutions to deliver an exceptionally broad range of aligned and specialized urology and urologic oncology services, led by eminent clinicians and thought leaders.

  • by

  • May 21, 2026

  • 3 min